Discontinuation report FLUOROURACIL INJECTION USP

Last updated on 2020-09-29 History
Report ID 125282
Drug Identification Number 02182742
Brand name FLUOROURACIL INJECTION USP
Common or Proper name Fluorouracil Injection USP
Company Name PFIZER CANADA ULC
Market Status MARKETED
Active Ingredient(s) FLUOROURACIL
Strength(s) 50MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 100mL vial
ATC code L01BC
ATC description ANTIMETABOLITES
Reason for discontinuation Business reasons
Anticipated discontinuation date 2020-11-30
Actual discontinuation date
Remaining supply date 2020-11-30
Discontinuation status To be discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments
Health Canada comments
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v2 2020-09-29 French Compare
v1 2020-09-29 English Compare